| MeSH term | MeSH ID | Detail |
|---|---|---|
| Arthritis, Rheumatoid | D001172 | 3 associated lipids |
| Liver Diseases | D008107 | 31 associated lipids |
| Occupational Diseases | D009784 | 42 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Leukemia P388 | D007941 | 43 associated lipids |
| Chemical and Drug Induced Liver Injury | D056486 | 39 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Myocardial Infarction | D009203 | 21 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kim YT et al. | Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. | 2007 | Gynecol. Oncol. | pmid:17234260 |
| Olas B et al. | Protective effects of D-glucaro 1,4-lactone against oxidative/nitrative modifications of plasma proteins. | 2007 | Nutrition | pmid:17234507 |
| Pai AB et al. | Effect of intravenous iron supplementation on hepatic cytochrome P450 3A4 activity in hemodialysis patients: a prospective, open-label study. | 2007 | Clin Ther | pmid:18201586 |
| Tryfinopoulou P et al. | Diversity of Shewanella population in fish Sparus aurata harvested in the Aegean Sea. | 2007 | J. Appl. Microbiol. | pmid:17714405 |
| Yew WS et al. | Evolution of enzymatic activities in the enolase superfamily: L-talarate/galactarate dehydratase from Salmonella typhimurium LT2. | 2007 | Biochemistry | pmid:17649980 |
| Hörl WH | Iron therapy for renal anemia: how much needed, how much harmful? | 2007 | Pediatr. Nephrol. | pmid:17206511 |
| Watanabe S et al. | alpha-ketoglutaric semialdehyde dehydrogenase isozymes involved in metabolic pathways of D-glucarate, D-galactarate, and hydroxy-L-proline. Molecular and metabolic convergent evolution. | 2007 | J. Biol. Chem. | pmid:17202142 |
| Vindal V et al. | GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. | 2007 | BMC Genomics | pmid:17714599 |
| Iversen C et al. | The taxonomy of Enterobacter sakazakii: proposal of a new genus Cronobacter gen. nov. and descriptions of Cronobacter sakazakii comb. nov. Cronobacter sakazakii subsp. sakazakii, comb. nov., Cronobacter sakazakii subsp. malonaticus subsp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov. and Cronobacter genomospecies 1. | 2007 | BMC Evol. Biol. | pmid:17439656 |
| Sato K | [Drug-induced osteomalacia]. | 2007 | Clin Calcium | pmid:17906405 |
| Toblli JE et al. | Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. | 2007 | J. Am. Coll. Cardiol. | pmid:17950147 |
| Francis GS and Kanderian A | Anemia and heart failure a new pathway? | 2007 | J. Am. Coll. Cardiol. | pmid:17950148 |
| Sav T et al. | Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? | 2007 | Ren Fail | pmid:17497463 |
| Pai AB et al. | Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. | 2007 | Pharmacotherapy | pmid:17316146 |
| Vikrant S | Optimum dosage regimen for iron sucrose. | 2007 | Kidney Int. | pmid:17625585 |
| Reed J et al. | The safety of intravenous iron sucrose use in the elderly patient. | 2007 | Consult Pharm | pmid:17658969 |
| Auerbach M and Rodgers GM | Intravenous iron. | 2007 | N. Engl. J. Med. | pmid:17611217 |
| Agarwal R et al. | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2007 | Kidney Int. | pmid:17622274 |
| Marsillach J et al. | Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia. | 2007 | Clin. Exp. Pharmacol. Physiol. | pmid:17324148 |
| George P et al. | Coronary artery vasospasm with iron sucrose. | 2007 | Nephrol. Dial. Transplant. | pmid:17327282 |
| Izuel Rami M et al. | [Budget impact analysis of a blood saving program for urgent traumatological surgery]. | 2007 | Med Clin (Barc) | pmid:17266885 |
| Grzegorzewska AE | [Administration of iron-containing drugs in non-dialyzed patients with chronic kidney disease]. | 2007 | Pol. Arch. Med. Wewn. | pmid:17722476 |
| Singh J and Gupta KP | Induction of apoptosis by calcium D-glucarate in 7,12-dimethyl benz [a] anthracene-exposed mouse skin. | 2007 | J. Environ. Pathol. Toxicol. Oncol. | pmid:17725531 |
| Thomas J and Martinez A | Blood conservation in the critically ill. | 2007 | Am J Health Syst Pharm | pmid:17687066 |
| Malindretos P et al. | Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. | 2007 | Am. J. Nephrol. | pmid:17804904 |
| Nakamura Y et al. | Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics. | 2008 | Drug Metab Lett | pmid:19356106 |
| Picker SM et al. | Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. | 2008 | Transfusion | pmid:18513255 |
| Pinsk V et al. | Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. | 2008 | Isr. Med. Assoc. J. | pmid:18605353 |
| Kaplinsky C | Parenteral iron therapy. | 2008 | Isr. Med. Assoc. J. | pmid:18605363 |
| Cuenca J et al. | Efficacy of intravenous iron sucrose administration for correcting preoperative anemia in patients scheduled for major orthopedic surgery. | 2008 | Anesthesiology | pmid:18580186 |
| Zółtaszek R et al. | [The biological role of D-glucaric acid and its derivatives: potential use in medicine]. | 2008 | Postepy Hig Med Dosw (Online) | pmid:18772850 |
| Stefánsson BV et al. | Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection. | 2008 | Free Radic. Biol. Med. | pmid:18775775 |
| Oleson L and Court MH | Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. | 2008 | J. Pharm. Pharmacol. | pmid:18718121 |
| Aghaie A et al. | New insights into the alternative D-glucarate degradation pathway. | 2008 | J. Biol. Chem. | pmid:18364348 |
| Al-Saran KA and Sabry AA | Pregnancy in dialysis patients: a case series. | 2008 | J Med Case Rep | pmid:18205953 |
| Bolaños L et al. | Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients. | 2008 | Adv Perit Dial | pmid:18986009 |
| Gonçalves P et al. | The effect of high glucose on SERT, the human plasmalemmal serotonin transporter. | 2008 | Nutr Neurosci | pmid:19000377 |
| Anirban G et al. | The comparative safety of various intravenous iron preparations in chronic kidney disease patients. | 2008 | Ren Fail | pmid:18661414 |
| Wang S et al. | Chemical reactions of vitamin C with intravenous-iron formulations. | 2008 | Nephrol. Dial. Transplant. | pmid:17951305 |
| Saluk-Juszczak J et al. | Protective effects of D-glucaro-1,4-lactone against oxidative modifications in blood platelets. | 2008 | Nutr Metab Cardiovasc Dis | pmid:17933501 |
| Roth S et al. | Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. | 2008 | Transl Res | pmid:18061126 |
| Liu Z et al. | Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. | 2008 | Nucl Med Commun | pmid:18094633 |
| Wall GC and Pauly RA | Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. | 2008 | Am J Health Syst Pharm | pmid:18192261 |
| Li H and Wang SX | Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. | 2008 | Blood Purif. | pmid:18212498 |
| Hasegawa K et al. | [Improvement of urinary d-glucaric acid assay and its application]. | 2008 | Yakugaku Zasshi | pmid:18176065 |
| Jaber BL | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2008 | Kidney Int. | pmid:18235527 |
| Olas B et al. | D-glucaro 1,4-lactone and resveratrol as antioxidants in blood platelets. | 2008 | Cell Biol. Toxicol. | pmid:17846905 |
| Auerbach M et al. | The role of intravenous iron in anemia management and transfusion avoidance. | 2008 | Transfusion | pmid:18346021 |
| Auerbach M and Al Talib K | Low-molecular weight iron dextran and iron sucrose have similar comparative safety profiles in chronic kidney disease. | 2008 | Kidney Int. | pmid:18274543 |
| Lord RS and Bralley JA | Clinical applications of urinary organic acids. Part I: Detoxification markers. | 2008 | Altern Med Rev | pmid:18950247 |